Abstract
LG-40. UNUSUAL NON-PILOCYTIC HISTOPATHOLOGICAL FEATURES OF PEDIATRIC INFRATENTORIAL GLIOMAS WITH BRAF FUSION GENE: A REPORT OF 2 CASES Christine Haberler1, Andreas Kiefer2, Barbara Jauk2, Christian Dorfer1, Thomas Czech1, Giles Vince2, Manuela Badiali3, and Irene Slavc1; Medical University of Vienna, Vienna, Austria; Academic Hospital of Klagenfurt, Klagenfurt, Austria; Microcitemico Hospital, Cagliari, Italy Genomic profiling studies have unraveled distinct molecular changes in different pediatric glioma entities. High grade gliomas commonly harbor H3F3A mutations or PDGFRA amplifications, diffuse low grade gliomas frequently display mutations in the FGFR1 or MYB1 gene, and pilocytic astrocytomas are characterized by MAPK pathway alterations including BRAF fusions and mutations. We report two infratentorial tumors with unusual morphological features. Patient 1 is a 15-year-old girl with a 6 months history of headache and a 4.5x4.5x6 cm cerebellar cystic tumor with contrast enhancement. A near gross total resection was performed. Histopathologically, the tumor was partly clear-celled but showed focally also some rosettes reminiscent of a RGNT. Vascular proliferations in a nonpilocytic tumor raised the suspicion of a malignant glioma. Patient 2, a 4-year-old girl presented with cephalea/strabism and had a cystic 2,8 x 2,9 x 2,5 cm tumor in the pineal region, radiologically compatible with a pilocytic astrocytoma. A gross total resection was performed. Histopathologically, ependymoma-like features with perivascular pseudorosettes, clear cells and vascular proliferations were present. In both cases immunhistochemical expression pattern confirmed a glioma without H3F3A K27M and BRAF V600E mutation, however classification and grading were difficult. Sequencing revealed in both tumors a KIAA1549– BRAF fusion. As this alteration is predominantly but not exclusively found in pilocytic astrocytomas and histopathologically no clear-cut signs ofmalignancy werepresent, no adjuvant treatment was administered. Both patients show no tumor recurrence/progression 32 and 21 months postoperatively. These cases emphasize the importance of molecular analyses in tumors with unusual morphological feature. Neuro-Oncology 18:iii78–iii96, 2016. doi:10.1093/neuonc/now075.40 #The Author(s) 2016. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.